181 related articles for article (PubMed ID: 21700719)
1. CrkL is a co-activator of estrogen receptor alpha that enhances tumorigenic potential in cancer.
Padmanabhan RA; Nirmala L; Murali M; Laloraya M
Mol Endocrinol; 2011 Sep; 25(9):1499-512. PubMed ID: 21700719
[TBL] [Abstract][Full Text] [Related]
2. The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
Franke FC; Müller J; Abal M; Medina ED; Nitsche U; Weidmann H; Chardonnet S; Ninio E; Janssen KP
Cell Mol Gastroenterol Hepatol; 2019; 7(1):33-53. PubMed ID: 30480076
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional basis of a role for CRKL in a fibroblast growth factor 8-induced feed-forward loop.
Seo JH; Suenaga A; Hatakeyama M; Taiji M; Imamoto A
Mol Cell Biol; 2009 Jun; 29(11):3076-87. PubMed ID: 19307307
[TBL] [Abstract][Full Text] [Related]
4. Decreased responsiveness of naturally occurring mutants of human estrogen receptor alpha to estrogens and antiestrogens.
Komagata S; Nakajima M; Tsuchiya Y; Katoh M; Kizu R; Kyo S; Yokoi T
J Steroid Biochem Mol Biol; 2006 Jul; 100(1-3):79-86. PubMed ID: 16713253
[TBL] [Abstract][Full Text] [Related]
5. Estrogenically regulated LRP16 interacts with estrogen receptor alpha and enhances the receptor's transcriptional activity.
Han WD; Zhao YL; Meng YG; Zang L; Wu ZQ; Li Q; Si YL; Huang K; Ba JM; Morinaga H; Nomura M; Mu YM
Endocr Relat Cancer; 2007 Sep; 14(3):741-53. PubMed ID: 17914104
[TBL] [Abstract][Full Text] [Related]
6. Modeling of molecular interaction between apoptin, BCR-Abl and CrkL--an alternative approach to conventional rational drug design.
Panigrahi S; Stetefeld J; Jangamreddy JR; Mandal S; Mandal SK; Los M
PLoS One; 2012; 7(1):e28395. PubMed ID: 22253690
[TBL] [Abstract][Full Text] [Related]
7. Kruppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells.
Velarde MC; Zeng Z; McQuown JR; Simmen FA; Simmen RC
Mol Endocrinol; 2007 Dec; 21(12):2988-3001. PubMed ID: 17717078
[TBL] [Abstract][Full Text] [Related]
8. The molecular basis of the interaction between the proline-rich SH3-binding motif of PNRC and estrogen receptor alpha.
Zhou D; Ye JJ; Li Y; Lui K; Chen S
Nucleic Acids Res; 2006; 34(20):5974-86. PubMed ID: 17068076
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of PROS1 gene expression by 17beta-estradiol via estrogen receptor alpha (ERalpha)-Sp1 interaction recruiting receptor-interacting protein 140 and the corepressor-HDAC3 complex.
Suzuki A; Sanda N; Miyawaki Y; Fujimori Y; Yamada T; Takagi A; Murate T; Saito H; Kojima T
J Biol Chem; 2010 Apr; 285(18):13444-53. PubMed ID: 20200160
[TBL] [Abstract][Full Text] [Related]
10. Nucleolar Sik-similar protein (Sik-SP) is required for the maintenance of uterine estrogen signaling mechanism via ERα.
Chung D; Gao F; Ostmann A; Hou X; Das SK
Mol Endocrinol; 2012 Mar; 26(3):385-98. PubMed ID: 22282469
[TBL] [Abstract][Full Text] [Related]
11. DNA homologous recombination factor SFR1 physically and functionally interacts with estrogen receptor alpha.
Feng Y; Singleton D; Guo C; Gardner A; Pakala S; Kumar R; Jensen E; Zhang J; Khan S
PLoS One; 2013; 8(7):e68075. PubMed ID: 23874500
[TBL] [Abstract][Full Text] [Related]
12. Novel DNA motif binding activity observed in vivo with an estrogen receptor α mutant mouse.
Hewitt SC; Li L; Grimm SA; Winuthayanon W; Hamilton KJ; Pockette B; Rubel CA; Pedersen LC; Fargo D; Lanz RB; DeMayo FJ; Schütz G; Korach KS
Mol Endocrinol; 2014 Jun; 28(6):899-911. PubMed ID: 24713037
[TBL] [Abstract][Full Text] [Related]
13. Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src.
Liu H; Qiu J; Li N; Chen T; Cao X
J Biol Chem; 2010 Jul; 285(29):21934-42. PubMed ID: 20460377
[TBL] [Abstract][Full Text] [Related]
14. Coactivation of estrogen receptor alpha (ER alpha)/Sp1 by vitamin D receptor interacting protein 150 (DRIP150).
Lee J; Safe S
Arch Biochem Biophys; 2007 May; 461(2):200-10. PubMed ID: 17306756
[TBL] [Abstract][Full Text] [Related]
15. Thrombopoietin induces association of Crkl with STAT5 but not STAT3 in human platelets.
Ozaki K; Oda A; Wakao H; Rhodes J; Druker BJ; Ishida A; Wakui M; Okamoto S; Morita K; Handa M; Komatsu N; Ohashi H; Miyajima A; Ikeda Y
Blood; 1998 Dec; 92(12):4652-62. PubMed ID: 9845531
[TBL] [Abstract][Full Text] [Related]
16. 17Beta-estradiol induces nuclear translocation of CrkL at the window of embryo implantation.
Nautiyal J; Kumar PG; Laloraya M
Biochem Biophys Res Commun; 2004 May; 318(1):103-12. PubMed ID: 15110759
[TBL] [Abstract][Full Text] [Related]
17. DNA binding by estrogen receptor-alpha is essential for the transcriptional response to estrogen in the liver and the uterus.
Ahlbory-Dieker DL; Stride BD; Leder G; Schkoldow J; Trölenberg S; Seidel H; Otto C; Sommer A; Parker MG; Schütz G; Wintermantel TM
Mol Endocrinol; 2009 Oct; 23(10):1544-55. PubMed ID: 19574448
[TBL] [Abstract][Full Text] [Related]
18. Direct binding of CRKL to BCR-ABL is not required for BCR-ABL transformation.
Heaney C; Kolibaba K; Bhat A; Oda T; Ohno S; Fanning S; Druker BJ
Blood; 1997 Jan; 89(1):297-306. PubMed ID: 8978305
[TBL] [Abstract][Full Text] [Related]
19. Nucleophosmin/B23 is a negative regulator of estrogen receptor α expression via AP2γ in endometrial cancer cells.
Lin CY; Chao A; Wang TH; Lee LY; Yang LY; Tsai CL; Wang HS; Lai CH
Oncotarget; 2016 Sep; 7(37):60038-60052. PubMed ID: 27527851
[TBL] [Abstract][Full Text] [Related]
20. Serine 28 phosphorylation of NRIF3 confers its co-activator function for estrogen receptor-alpha transactivation.
Talukder AH; Li DQ; Manavathi B; Kumar R
Oncogene; 2008 Sep; 27(39):5233-42. PubMed ID: 18521086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
